Scientists in the UK have used a revolutionary new type of gene therapy to treat a young patient with relapsed T-cell leukaemia. The...

St. Jude scientists helped lead a comprehensive genomic analysis to uncover the impact of genes on the treatment and outcome of the...

Scientists from St. Jude Children’s Research Hospital have created an LCK targeted PROTAC, demonstrating its enhanced ability to kill...

Newly published research carried out using synthetic human bone marrow cells is paving the way for the development of safer and kinder...

An international research team coordinated by Dr. Oscar Molina and Dr. Pablo Menéndez, from the Josep Carreras Leukaemia Research ...

A recent study involving children with hematologic malignancies has suggested that mutations in a portion of a cohesin gene known as...

Young adults who have survived leukemia have higher mortality rates than people in the general population, even for decades after their ...

New research has begun to unravel the mystery of why a particular form of leukaemia in infants has defied efforts to improve outcomes,...

Childhood acute leukemia survivors with Down syndrome had increased risk for late mortality not attributable to cardiac- or subsequent ...

Blocking a protein chain reaction makes childhood leukemia cells more sensitive to an existing targeted treatment, a new study shows....